Department of Oral and Maxillofacial Surgery, University of Erlangen- Nuremberg, Erlangen, Germany.
Head of the Department of Oral and Maxillofacial Surgery, University of Erlangen- Nuremberg, Germany.
Cranio. 2024 Jan;42(1):1-9. doi: 10.1080/08869634.2021.1885886. Epub 2021 Feb 16.
Symptoms of temporomandibular dysfunction (TMD) may include pain in the muscles or restrictions opening the mouth. The aim of this study was to assess the effects of initial Aqualizer™ therapy.
Group 1 received initial Aqualizer™ therapy before definitive hard splint; Group 2 received no initial therapy. Patients with arthrosis, partial/total prosthesis or undergoing splint therapy were excluded. Objective (temporomandibular joint palpation, temporomandibular joint auscultation, palpation of the chewing muscles, and mobility of the lower jaw) parameters were evaluated. The level of statistical significance was 5% ( < 0.05).
In 53 patients (Group 1 n = 25; Group 2 n = 28), a significant improvement ( < 0.001) was found in Group 1 in pain on palpation (masseter muscle, temporal muscle, post-mandibular region, lateral pterygoid muscle, and suboccipital region), but no significant differences in jaw mobility were found.
Aqualizer™ therapy produces significant improvement of primary symptoms.
颞下颌功能紊乱（TMD）的症状可能包括肌肉疼痛或张口受限。本研究旨在评估初始 Aqualizer™治疗的效果。
第 1 组在使用硬性夹板前接受初始 Aqualizer™治疗；第 2 组未接受初始治疗。排除关节炎、部分/全口义齿或正在接受夹板治疗的患者。评估客观（颞下颌关节触诊、颞下颌关节听诊、咀嚼肌触诊和下颌运动）参数。统计显著性水平为 5%（<0.05）。
在 53 名患者中（第 1 组 n=25；第 2 组 n=28），第 1 组在触诊时的疼痛（咀嚼肌、颞肌、下颌后区、翼外肌和枕下区）显著改善（<0.001），但下颌运动无明显差异。
Aqualizer™治疗可显著改善主要症状。
Zotero 插件